Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03210831 · ClinicalTrials.gov registry record
Early Predictors of Necrotizing Enterocolitis in Neonates
A clinical trial of Necrotizing Enterocolitis, sponsored by Nationwide Children's Hospital.
- Recruiting
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT03210831 is a study of Necrotizing Enterocolitis that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 450 participants, above the 281-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (60% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03210831, a study of Necrotizing Enterocolitis, is actively recruiting participants, sponsored by Nationwide Children's Hospital.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to institute or test treatments in the long term to prevent the progression of the disease in these infants.
Conditions Studied
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03210831
The ClinicalTrials.gov registry entry for NCT03210831 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 281-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (60% higher). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Necrotizing Enterocolitis appearing as the primary indexed condition, and to 0 interventions.
NCT03210831 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03210831 about?
NCT03210831 is a clinical study titled "Early Predictors of Necrotizing Enterocolitis in Neonates". The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identi...
What is the current status of trial NCT03210831?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2017-09-06. Estimated completion is 2026-12.
What conditions does trial NCT03210831 study?
This clinical trial studies the following conditions: Necrotizing Enterocolitis.
Who is sponsoring clinical trial NCT03210831?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03210831 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Necrotizing Enterocolitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
RECRUITING · Phase 1
-
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
RECRUITING · NA
-
A Cohort Study of the Intestinal Microbiota of Premature Infants
ACTIVE NOT RECRUITING
-
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
ACTIVE NOT RECRUITING · Phase 3
-
RBC Irradiation, Anemia and Gut Injury
ACTIVE NOT RECRUITING
-
RIC-NEC Randomized Controlled Trial
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.